Search results

Skip to results

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Showing 1 to 4 of 4 results for tirzepatide

  1. Tirzepatide for treating type 2 diabetes (TA924)

    Evidence-based recommendations on tirzepatide (Mounjaro) for type 2 diabetes in adults.

    Technology appraisal guidance
    Published
    25 October 2023
    View recommendations

    Sections for TA924

  2. Tirzepatide for managing overweight and obesity [ID6179]

    In development [GID-TA11156] Expected publication date: 19 June 2024

    Technology appraisal guidance
    In development

  3. NICE committee recommends tirzepatide as new treatment option for people with type 2 diabetes

    Around 180,000 people with difficult to manage type 2 diabetes could benefit from a new treatment option recommended by NICE

    News
    Published
    8 September 2023

  4. More evidence needed to recommend Type 2 diabetes treatment tirzepatide

    More evidence is needed on the clinical and cost-effectiveness of a new treatment option for people with type 2 diabetes before it could be recommended for NHS use, a NICE committee has said.

    News
    Published
    27 June 2023